Canaccord Genuity Maintains a 'Sell' on Seattle Genetics (SGEN); Adcetris Launch Ahead

August 23, 2011 8:30 AM EDT Send to a Friend
Canaccord Genuity maintains a 'Sell' on Seattle Genetics (NASDAQ: SGEN) price target of $10.00.

Canaccord analyst, George Farmer, said, "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login